News archivos - Mikrobiomik

Clostridium Difficile MBK-01 Microbiome News

Mikrobiomik is set to launch Spain’s first human microbiome therapy in 2026

At Mikrobiomik, we are moving towards a new milestone in microbiome-based medicine. Bilbao,…

elen9miKK03/02/2026

Biological medicine MBK-01 Microbiota News

MBK-01 demonstrates its clinical impact against Clostridioides difficile infection

A real-life case shows how a microbiota-based therapy can provide an effective alternative when conventional…

elen9miKK07/01/2026

Clinical trials MBK-01 News

First patient for phase III trial in decompensated liver cirrhosis

A new milestone achieved: the first patient is recruited for the phase III trial in…

elen9miKK29/07/2025

Mikrobiomik se une al European Microbiome Innovation for Health (EMIH)

Corporativas Microbiota News

Mikrobiomik joins the European Microbiome Innovation for Health (EMIH)

We are thrilled to announce that we are part of the European Microbiome Innovation for…

elen9miKK23/07/2025

Biological medicine Clostridium Difficile Microbiota News

We have launched a €500,000 round on Capital Cell

10/07/2025 We have launched a €500,000 round on Capital Cell to launch the first oral…

elen9miKK10/07/2025

Clinical trials News

The future for diverticulitis is already here

The future for diverticulitis is already here. Mikrobiomik recruits the first patient in a trial…

elen9miKK08/04/2025

La EMA aprueba el Plan de Investigación Pediátrica (PIP) para MBK-01

Clostridium Difficile European Medicines Agency News

Good news: EMA approves Paediatric Investigation Plan (PIP) for MBK-01

14/02/2025 Mikrobiomik has reached a new milestone upon receiving the approval of the Paediatric Investigation…

elen9miKK14/02/2025

MBK-01 es la innovación sanitaria más destacada del mundo

Corporativas News

Global recognition: MBK-01 is the world’s most outstanding healthcare innovation in 2024

20/01/2025 Mikrobiomik Health Company has reached a new milestone by being recognised twice at the…

elen9miKK20/01/2025

La AEMPS autoriza el ensayo clínico DIREBIOT

Clinical trials Corporate Corporativas News

The AEMPS authorizes DIREBIOT clinical trial

02/12/2024 Mikrobiomik in association with IRYCIS (Instituto Ramón y Cajal de Investigación Sanitaria) are launching…

elen9miKK02/12/2024

Patricia del Río, nueva directora ejecutiva de Mikrobiomik

Corporate Corporativas News

Patricia del Río, new executive director

02/12/2024 Patricia del Río, new executive director: female leadership at the forefront of our mission…

elen9miKK02/12/2024

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necesary

Always Enabled

Functional

Analytics

Others

Perfomance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Cookie	Duration	Description
YSC	session	This cookies is set by Youtube and is used to track the views of embedded videos.

News50